Nasdaq suspends trading in Charming Medical shares effective Nov. 9
MCTA•Nasdaq will suspend trading in Charming Medical securities at the opening of business on Nov. 9, 2026, after the company missed a hearing deadline following an Oct. 29 delisting determination. The delisting will not immediately affect ongoing operations or financial condition.
1. Suspension and delisting
Nasdaq will suspend trading in Charming Medical securities at the opening of business on Nov. 9, 2026, and remove them from listing. The company missed a Nov. 5 hearing deadline after Nasdaq issued a delisting determination on Oct. 29. Nasdaq's halt has been in effect since Nov. 26, 2025, after the SEC suspended trading from Nov. 12 to Nov. 25, 2025, over potential third-party manipulation. The delisting determination has no immediate effect on the company's ongoing operations or financial condition.
